BBC logo

Virtus LifeSci Biotech Clinical Trials ETF (BBC)

$44.22

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BBC

AUM

$37586497

P/E ratio

7.4

Dividend yield

1.4922%

Expense ratio

0.65%

Beta

0.913282

Price on BBC

Previous close

$46.02

Today's open

$46.04

Day's range

$43.60 - $46.04

52 week range

$16.76 - $48.18

Profile about BBC

show more

Headquarters

US

Exchange

NYSE Arca

Issue type

Exchange-Traded Fund

BBC industries and sectors

Industries

Health

Top holdings in BBC
News on BBC

Medical Technology Stocks: Innovation Endures As Valuations Reset

Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.

news source

Seeking Alpha • May 2, 2026

news preview

Global PMI: Tracking The Sectors Hit Hardest By The Middle East War

Survey data underscored how the war in the Middle East has already had a material impact on economic growth around the world. Drilling down deeper, the data showed weaker growth trends were recorded across all major industries globally.

news source

Seeking Alpha • Apr 12, 2026

news preview

Can Forgotten Biotech Break Out?

After a 50%+ run from lows last April through highs in mid-January, the Biotech group has been trending sideways over the last few months. Biotech hasn't garnered much attention lately, with all the coverage of the Iran War and the AI Doom trade that's been taking down software stocks even as AI infrastructure stocks continue to surge.

news source

Seeking Alpha • Apr 11, 2026

news preview

Biotech ETF (BBC) Touches Fresh 52-Week High

Biotech ETF BBC hits a 52-week high, likely fueled by strong clinical trial results and rising M&A activity, and renewed risk-on sentiment.

news source

Zacks Investment Research • Apr 10, 2026

news preview

Can ETF Winners of Q4 of 2025 Rally in Q1 of 2026?

Wall Street put up a modest show in the final quarter of 2025, with the S&P 500 advancing only 1.9%, the Dow Jones gaining 3.3% and the Nasdaq Composite adding about 2.1%. The small-cap index Russell 2000 added 1.6% during that period.

news source

Zacks Investment Research • Jan 6, 2026

news preview

Biotech ETF (BBC) Hits New 52-Week High

Biotech ETF BBC hits a 52-week high amid renewed sector momentum, Fed rate cuts and AI-driven healthcare gains, hinting at more near-term upside.

news source

Zacks Investment Research • Dec 1, 2025

news preview

Best-Performing ETFs of Last Week: Healthcare Rules

Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.

news source

Zacks Investment Research • Nov 24, 2025

news preview

Investing In Health Stocks - How Policy Clarity Is Opening Doors

The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.

news source

Seeking Alpha • Nov 11, 2025

news preview

Trade War or Not, Specific Industry ETFs Are in Sweet Spots

Trade war jitters rise, but ETFs like MSOS, SILJ, SGDJ, BBC, WISE & CTEX shine on solid fundamentals, offering either safe havens or growth potential.

news source

Zacks Investment Research • Oct 16, 2025

news preview

Healthcare Sector Checkup As U.S. Looks To Change Regulations

Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.

news source

Seeking Alpha • May 30, 2025

news preview

¹ Disclosures

Get started with M1

Invest in Virtus LifeSci Biotech Clinical Trials ETF

Open an M1 investment account to buy and sell Virtus LifeSci Biotech Clinical Trials ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BBC on M1